Maria Chukwuma

Mrs. Maria Chukwuma

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ANAdeline Lum Nde
Adeline Lum Nde
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
OEOchuko Lucky Erukainure
Ochuko Lucky Erukainure
MCMaria Chukwuma
Maria Chukwuma
MMMotlalepula Matsabisa
Motlalepula Matsabisa

14 October 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
Gloria Otito IzuGloria Otito Izu
Gloria Otito Izu
NMNomonde P. Mapasa
Nomonde P. Mapasa
JNJennifer Nambooze
Jennifer Nambooze
MCMaria Chukwuma
Maria Chukwuma
Emmanuel Mfotie NjoyaEmmanuel Mfotie Njoya
Emmanuel Mfotie Njoya
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
Bioactive flavonoid epicatechin has been reported in the peel of litchi fruit but isolated from its hydroalcoholic extracts. This study isolated epicatechin with cellular glucose uptake modulatory and ROS production inhibitory properties from the ethyl acetate (EtOAc) extract using a bioassay-guided approach. The fruit peel was defatted with hexane and sequentially extracted using dichloromethane (DCM), EtOAc, methanol (MeOH) and water. In vitro phytochemical models, namely antioxidant (Fe3+ reducing, radical scavenging and anti-linoleic acid peroxidative) and glycaemic control (α-glucosidase and α-amylase inhibitory and glucose uptake modulatory), were employed for the bioassay-guided isolation, while the isolated compound was characterised using NMR and mass spectrometry and assessed for dose-dependent inhibition of α-glucosidase and lipopolysaccharide (LPS)-induced cellular ROS production, as well as modulation of cellular glucose uptake. Relative to the other extracts, the EtOAc extract had appreciable phenol and flavonoid contents, which perhaps influenced its potent anti-lipid peroxidative (65.0%) and α-glucosidase inhibitory (52.4%) effects. The α-glucosidase inhibitory potency of the fractions (1–8) from the EtOAc extracts correlated with their flavonoid contents, with fraction 5 outperforming other fractions. The fraction comprised a pool of fractions obtained from the DCM:MeOH:water (7:3:0.281 v/v/v) solvent system. LC-MS revealed the predominant presence of epicatechin in fraction 5, which was later isolated from one of the sub-fractions (sub-fraction 4) of fraction 5. This sub-fraction had stronger anti-lipid peroxidative (65.5%), α-glucosidase inhibitory (65.8%) and glucose uptake modulatory (38.2%) effects than the other sub-fractions from fraction 5, which could have been influenced by the isolated epicatechin. Moreover, the isolated epicatechin inhibited α-glucosidase (IC50 = 35.3 µM), modulated cellular glucose uptake (EC50 = 78.5 µM) and inhibited LPS-induced ROS production in RAW 264.7 macrophages in a dose-dependent fashion [IC50 = 18.9 µM; statistically comparable (p > 0.05) to ascorbic acid, IC50 = 9.57 µM]. Epicatechin from litchi peel EtOAc extract could potentiate glucose uptake modulatory, α-glucosidase inhibitory and ROS suppressive capacities, which could be influential in the use of litchi fruit peel for managing diabetes and associated oxidative damage.

29 August 2025 in Molecules
Verified
Journal Article
Open access
PDF file
MCMaria Chukwuma
Maria Chukwuma
LBLorenza Bertaina
Lorenza Bertaina
SKSophia Khom
Sophia Khom
CCChika Ifeanyi Chukwuma
Chika Ifeanyi Chukwuma
PZPieter C. Zietsman
Pieter C. Zietsman
SBSusan L. Bonnet
Susan L. Bonnet
This study aimed to investigate the glycaemic control potential and modulation of GABA-induced chloride currents (IGABA) of H. revolutum and the possible bioactive xanthones. Fractions from the leaf and stem extracts (dichloromethane and methanol) were assessed for in vitro α-glucosidase-inhibitory potential and their ability to modulate IGABA (GABAergic effect) through GABAA receptors heterologously expressed in Xenopus oocytes. Xanthones 4-hydroxy-2,3-dimethoxy-9H-xanthen-9-one (1), 3-hydroxy-2,4-dimethoxy-9H-xanthen-9-one (2) and trans-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydro-7H-[1,4]dioxino[2,3-c]xanthen-7-one (3) were isolated from the stem and tested in the GABAA receptors assay, but only 3 was assessed for α-glucosidase-inhibitory action. Compared to acarbose (IC50 = 6.16 µM), 3 showed a mild to moderate α-glucosidase-inhibitory activity (IC50 = 45.1 µM), which may be attributed to the absence of a hydroxyl group at its xanthone core. Isomeric compounds 1 and 2 significantly enhanced IGABA with similar efficacy, while 3 was inactive, which may be attributed to its notable structural difference (cyclic ether substitution) compared to compounds 1 and 2. H. revolutum stem contains xanthones with α-glucosidase-inhibitory potential, which also enhance IGABA and could be further studied as a medicinal plant for managing GABAA receptor-mediated mental disorders and/or diabetes.